KZR
Kezar Life Sciences (KZR)
$12
About Kezar Life Sciences (KZR)
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.
Details
Daily high
$6.15
Daily low
$6.03
Price at open
$6.03
52 Week High
$6.57
52 Week Low
$3.53
Market cap
44.8M
Dividend yield
0.00%
Volume
16,928
Avg. volume
27,662
P/E ratio
-.72
Kezar Life Sciences News
Details
Daily high
$6.15
Daily low
$6.03
Price at open
$6.03
52 Week High
$6.57
52 Week Low
$3.53
Market cap
44.8M
Dividend yield
0.00%
Volume
16,928
Avg. volume
27,662
P/E ratio
-.72